Pflieger, LT; Dansithong, W; Paul, S; Scoles, DR; Figueroa, KP; Meera, P; Otis, TS; ... Pulst, SM; + view all Pflieger, LT; Dansithong, W; Paul, S; Scoles, DR; Figueroa, KP; Meera, P; Otis, TS; Facelli, JC; Pulst, SM; - view fewer (2017) Gene co-expression network analysis for identifying modules and functionally enriched pathways in SCA2. Human Molecular Genetics , 26 (16) pp. 3069-3080. 10.1093/hmg/ddx191.

Preview

Text Pflieger transcriptome ms 2017.pdf - Accepted Version Download (1MB) | Preview

Abstract

Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominant neurodegenerative disease caused by CAG repeat expansion in the ATXN2 gene. The repeat resides in an encoded region of the gene resulting in polyglutamine (polyQ) expansion which has been assumed to result in gain of function, predominantly, for the ATXN2 protein. We evaluated temporal cerebellar expression profiles by RNA sequencing of ATXN2Q127 mice versus wild-type (WT) littermates. ATXN2Q127 mice are characterized by a progressive motor phenotype onset, and have progressive cerebellar molecular and neurophysiological (Purkinje cell firing frequency) phenotypes. Our analysis revealed previously uncharacterized early and progressive abnormal patterning of cerebellar gene expression. Weighted Gene Coexpression Network Analysis revealed four gene modules that were significantly correlated with disease status, composed primarily of genes associated with GTPase signaling, calcium signaling and cell death. Of these genes, few overlapped with differentially expressed cerebellar genes that we identified in Atxn2−/− knockout mice versus WT littermates, suggesting that loss-of-function is not a significant component of disease pathology. We conclude that SCA2 is a disease characterized by gain of function for ATXN2.

Download activity - last month

Export as JSONXMLCSV

Download activity - last 12 months

Export as CSVJSONXML

Downloads by country - last 12 months

Export as JSONXMLCSV

Archive Staff Only

View Item